NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. From Molecules to Minds: Challenges for the 21st Century: Workshop Summary. Washington (DC): National Academies Press (US); 2008.

Cover of From Molecules to Minds

From Molecules to Minds: Challenges for the 21st Century: Workshop Summary.

Show details

Forum on Neuroscience and Nervous System Disorders*

ALAN LESHNER (Chair), American Association for the Advancement of Science, Washington, DC

HUDA AKIL, University of Michigan–Ann Arbor

MARC BARLOW, GE Healthcare, Inc., Buck, United Kingdom

DANIEL BURCH, CeNeRx Biopharma, Research Triangle Park, NC

DENNIS CHOI, Emory University, Atlanta, GA

TIMOTHY COETZEE, National Multiple Sclerosis Society, New York

DAVID COHEN, Columbia University, Society for Neuroscience representative, New York

RICHARD FRANK, GE Healthcare, Inc., Princeton, NJ

RICHARD HODES, National Institute on Aging, Bethesda, MD

STEVEN HYMAN, Harvard University, Cambridge, MA

JUDY ILLES, University of British Columbia, Vancouver, Canada

THOMAS INSEL, National Institute of Mental Health, Bethesda, MD

STORY LANDIS, National Institute of Neurological Disorders and Stroke, Bethesda, MD

TING-KAI LI, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD

HUSSEINI MANJI, Johnson & Johnson Pharmaceutical Research and Development, Inc., Titusville, NJ (since September 2008)

MICHAEL OBERDORFER, National Institutes on Health Neuroscience Blueprint, Bethesda, MD

KATHIE OLSEN, National Science Foundation, Arlington, VA

ATUL PANDE, GlaxoSmithKline, Inc., Research Triangle Park, NC

MENELAS PANGALOS, Wyeth Research, Inc., Princeton, NJ

STEVEN PAUL, Eli Lilly and Company, Indianapolis, IN

WILLIAM POTTER, Merck Research Laboratories, Inc., North Wales, PA

SCOTT REINES, Foundation for the NIH, Bethesda, MD

PAUL SIEVING, National Eye Institute, Bethesda, MD

RAE SILVER, Columbia University, New York

WILLIAM THIES, Alzheimer’s Association, Chicago, IL

ROY TWYMAN, Johnson & Johnson Pharmaceutical Research and Development, Inc., Titusville, NJ (until September 2008)

NORA VOLKOW, National Institute on Drug Abuse, Bethesda, MD

FRANK YOCCA, AstraZeneca Pharmaceuticals, Wilmington, DE

CHRISTIAN ZIMMERMAN, Neuroscience Associates, Boise, ID

IOM Staff

BRUCE ALTEVOGT, Forum Director

SARAH HANSON, Senior Program Associate

LORA TAYLOR, Senior Project Assistant

DIONNA ALI, Anderson Intern

Footnotes

*

IOM forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Copyright © 2008, National Academy of Sciences.
Bookshelf ID: NBK50994

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (527K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...